[topsearch__bar__shortcode]

September 3, 2024

Shoals (SHLS) Stock Rallies In Pre-Market Trading After Legal Victory

Shoals Technologies Group, Inc. (NASDAQ: SHLS) shares are experiencing a notable rise on the US stock charts, following a favorable litigation ruling. As of the latest pre-market review, SHLS shares have surged by 27.06%, trading at $6.85. This uptick in stock price comes in the wake of a significant legal triumph for the company. ITC […]

Shoals (SHLS) Stock Rallies In Pre-Market Trading After Legal Victory Read More »

Vaxcyte (PCVX) Shares Surge In Pre-Market On The Back of Promising Study Findings

Vaxcyte, Inc. (NASDAQ: PCVX) is seeing a significant rise in its shares this morning, climbing 35.85% to $109.71 during the pre-market session. This increase comes after the PCVX revealed positive topline results from a recent Phase 1/2 clinical research. Vaxcyte Reported Encouraging Research Results for VAX-31 Vaxcyte has released positive topline findings from a Phase

Vaxcyte (PCVX) Shares Surge In Pre-Market On The Back of Promising Study Findings Read More »

Envoy Medical (COCH) Stock Soars In Pre-Market Session After Latest Expansion Update

Shares of Envoy Medical, Inc. (NASDAQ: COCH) are experiencing notable gains in the pre-market session today, reflecting a rise of 9.93% to $3.32 per share. This upward movement follows the recent announcement of a strategic expansion by the company. Envoy Medical Secured New Funding Envoy Medical has secured an additional lending facility through its long-time

Envoy Medical (COCH) Stock Soars In Pre-Market Session After Latest Expansion Update Read More »

Lexaria Bioscience (LEXX) Experiences Continued Stock Surge

Last Friday, Lexaria Bioscience Corp. (NASDAQ: LEXX) had outstanding stock performance for the third day in a row, helped by encouraging findings from a recent pilot clinical research. The company’s stock increased by 21.05% to close at $3.91 after rising by more than 10% the day before. Lexaria Shared Clinical Research Success The results of

Lexaria Bioscience (LEXX) Experiences Continued Stock Surge Read More »

WORK Medical (WOK) Shares Climb Substantially Following Equity Strategy

WORK Medical Technology Group LTD (NASDAQ: WOK) shares witnessed a significant rise on the US stock charts last Friday. The stock surged by 22.39%, closing the trading session at $4.81. This sharp increase in value followed strategic equity moves by the company, enhancing investor confidence and market interest. WORK Medical Underwriter Exercised Partial Over-Allotment According

WORK Medical (WOK) Shares Climb Substantially Following Equity Strategy Read More »

After-Market Gains: Zhibao (ZBAO) Stock Soared On New Contract

Zhibao Technology Inc. (NASDAQ: ZBAO) stock witnessed a notable after-market surge on last Friday, reflecting investor optimism following the announcement of a significant new contract. ZBAO shares rose 16.67% after close of the market, bringing the stock price to $3.92. Zhibao Formed A Strategic Partnership Zhibao Technology disclosed its successful bid to provide high-end medical

After-Market Gains: Zhibao (ZBAO) Stock Soared On New Contract Read More »

InFinT (IFIN) Sees After-Market Rally Following Business Combination Announcement

The announcement of a successful business combination significantly impacted InFinT Acquisition Corporation’s (NYSE: IFIN) stock performance, leading to a notable recovery after market close. IFIN shares surged by 19.11% in after-hours trading, reaching $7.48, following a substantial 37.20% decline during the regular trading session, where the stock closed at $6.28. Completion of Business Combination and

InFinT (IFIN) Sees After-Market Rally Following Business Combination Announcement Read More »